← Back to Search

90Second IBD for Inflammatory Bowel Disease

N/A
Waitlist Available
Research Sponsored by Jennifer Jones
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Adult, resident of Canada, diagnosis of IBD, access to a computer or cell phone
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12
Awards & highlights
No Placebo-Only Group

Summary

This trial will explore a novel way to help IBD patients manage their psychological issues, and improve their quality of life.

Who is the study for?
This trial is for adults living in Canada who have been diagnosed with Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis. Participants must have access to a computer or cell phone.
What is being tested?
The '90Second IBD' intervention, an online health letter delivered weekly, is being tested to see if it improves the quality of life and self-efficacy in IBD patients by providing integrated medical and psychosocial information.
What are the potential side effects?
Since '90Second IBD' involves receiving educational health letters, there are no direct physical side effects associated with typical medical interventions. However, individual reactions to the content may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
IBD Specific Quality of life
Self Efficacy
Secondary study objectives
Participant Satisfaction with 90SecondIBD

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 90Second IBDExperimental Treatment1 Intervention
Participants will receive 90SecondIBD weekly at no charge via text message or email linked to a website.

Find a Location

Who is running the clinical trial?

Jennifer JonesLead Sponsor
2 Previous Clinical Trials
302 Total Patients Enrolled
90 Second HealthUNKNOWN
TakedaIndustry Sponsor
1,240 Previous Clinical Trials
4,147,677 Total Patients Enrolled
~0 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top